Alexandre Prieur
Grabels, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The lung cancer-associated blood biomarker hPG80 exhibits a reversible increase in response to smoking in asymptomatic individuals.
Journal: Biomarker research
Published: August 19, 2025
Evaluation of hPG80 (Circulating Progastrin) as a Diagnostic Biomarker for Early Detection of Breast Cancer in Young Women in the United Arab Emirates.
Journal: Cancer diagnosis & prognosis
Published: July 31, 2025
Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
Journal: Cancers
Published: December 27, 2021
hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors.
Journal: Cancers
Published: December 07, 2021
A novel method to detect hPG80 (human circulating progastrin) in the blood.
Journal: Analytical methods : advancing methods and applications
Published: September 08, 2021
Prognostic Value of Plasma hPG80 (Circulating Progastrin) in Metastatic Renal Cell Carcinoma.
Journal: Cancers
Published: November 23, 2020
Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 22, 2017
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 14, 2013
Last Updated: 09/26/2026